[HTML][HTML] The mechanisms of pharmacokinetic food-drug interactions–A perspective from the UNGAP group

M Koziolek, S Alcaro, P Augustijns, AW Basit… - European Journal of …, 2019 - Elsevier
The simultaneous intake of food and drugs can have a strong impact on drug release,
absorption, distribution, metabolism and/or elimination and consequently, on the efficacy …

Overcoming the blood–brain tumor barrier for effective glioblastoma treatment

O Van Tellingen, B Yetkin-Arik, MC De Gooijer… - Drug Resistance …, 2015 - Elsevier
Gliomas are the most common primary brain tumors. Particularly in adult patients, the vast
majority of gliomas belongs to the heterogeneous group of diffuse gliomas, ie. glial tumors …

Predicting clearance mechanism in drug discovery: extended clearance classification system (ECCS)

MV Varma, SJ Steyn, C Allerton, AF El-Kattan - Pharmaceutical research, 2015 - Springer
Early prediction of clearance mechanisms allows for the rapid progression of drug discovery
and development programs, and facilitates risk assessment of the pharmacokinetic …

The role of structure and biophysical properties in the pleiotropic effects of statins

C Murphy, E Deplazes, CG Cranfield… - International journal of …, 2020 - mdpi.com
Statins are a class of drugs used to lower low-density lipoprotein cholesterol and are
amongst the most prescribed medications worldwide. Most statins work as a competitive …

Intracellular drug concentrations and transporters: measurement, modeling, and implications for the liver

X Chu, K Korzekwa, R Elsby, K Fenner… - Clinical …, 2013 - Wiley Online Library
Intracellular concentrations of drugs and metabolites are often important determinants of
efficacy, toxicity, and drug interactions. Hepatic drug distribution can be affected by many …

Drug induced liver injury (DILI). Mechanisms and medicinal chemistry avoidance/mitigation strategies

BH Norman - Journal of medicinal chemistry, 2020 - ACS Publications
Adverse drug reactions (ADRs) are a common cause of attrition in drug discovery and
development and drug-induced liver injury (DILI) is a leading cause of preclinical and …

[HTML][HTML] Pharmacokinetics and toxicity of tacrolimus early after heart and lung transplantation

MA Sikma, EM Van Maarseveen… - American Journal of …, 2015 - Elsevier
Annually, about 8000 heart and lung transplantations are successfully performed worldwide.
However, morbidity and mortality still pose a major concern. Renal failure in heart and lung …

Physiologically‐based pharmacokinetic models for evaluating membrane transporter mediated drug–drug interactions: current capabilities, case studies, future …

KS Taskar, V Pilla Reddy, H Burt… - Clinical …, 2020 - Wiley Online Library
Physiologically‐based pharmacokinetic (PBPK) modeling has been extensively used to
quantitatively translate in vitro data and evaluate temporal effects from drug–drug …

Coproporphyrins in plasma and urine can be appropriate clinical biomarkers to recapitulate drug-drug interactions mediated by organic anion transporting polypeptide …

Y Lai, S Mandlekar, H Shen, VK Holenarsipur… - … of Pharmacology and …, 2016 - ASPET
In the present study, an open-label, three-treatment, three-period clinical study of
rosuvastatin (RSV) and rifampicin (RIF) when administered alone and in combination was …

Intestinal drug interactions mediated by OATPs: a systematic review of preclinical and clinical findings

J Yu, Z Zhou, J Tay-Sontheimer, RH Levy… - Journal of …, 2017 - Elsevier
In recent years, an increasing number of clinical drug–drug interactions (DDIs) have been
attributed to inhibition of intestinal organic anion-transporting polypeptides (OATPs); …